Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study

被引:16
作者
Kim, Hyung-Jun [1 ]
Lee, Jong Hyuk [2 ]
Yoon, Soon Ho [2 ]
Kim, Sung A. [1 ]
Kim, Myoung Sil [1 ]
Choi, Sun Mi [1 ]
Lee, Jinwoo [1 ]
Lee, Chang-Noon [1 ]
Han, Sung Koo [1 ]
Yim, Jae-Joon [1 ]
机构
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea
关键词
Clinical medicine; Cohort studies; Diagnosis; Nontuberculous mycobacteria; Progression; LUNG-DISEASE; INDUCED SPUTUM; EPIDEMIOLOGY; AVIUM; ABSCESSUS; IDENTIFICATION; TUBERCULOSIS; PROGRESSION;
D O I
10.1186/s12879-019-4078-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundMicrobiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types.MethodsWe analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens.ResultsThree hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George's Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion.ConclusionsAlthough some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study
    Hyung-Jun Kim
    Jong Hyuk Lee
    Soon Ho Yoon
    Sung A. Kim
    Myoung Sil Kim
    Sun Mi Choi
    Jinwoo Lee
    Chang-Hoon Lee
    Sung Koo Han
    Jae-Joon Yim
    BMC Infectious Diseases, 19
  • [2] Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease Secondary Analysis of a Prospective Cohort Study
    Hyung, Kwonhyung
    Kim, Sung-A
    Kim, Joong-Yub
    Kwak, Nakwon
    Yim, Jae-Joon
    CHEST, 2024, 166 (03) : 452 - 460
  • [3] Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study
    Kim, Soo Jung
    Yoon, Soon Ho
    Choi, Sun Mi
    Lee, Jinwoo
    Lee, Chang-Hoon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC PULMONARY MEDICINE, 2017, 17
  • [4] Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study
    Mori, Shunsuke
    Koga, Yukinori
    Nakamura, Kazuyoshi
    Hirooka, Sayuri
    Matsuoka, Takako
    Uramoto, Hideshi
    Sakamoto, Osamu
    Ueki, Yukitaka
    PLOS ONE, 2020, 15 (12):
  • [5] Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review
    Prevots, D. Rebecca
    Marshall, Julia E.
    Wagner, Dirk
    Morimoto, Kozo
    CLINICS IN CHEST MEDICINE, 2023, 44 (04) : 675 - 721
  • [6] Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease A Prospective Cohort Study in South Korea
    Jung, Hae In
    Kim, Sung A.
    Kim, Hyung-Jun
    Yim, Jae-Joon
    Kwak, Nakwon
    CHEST, 2022, 161 (04) : 918 - 926
  • [7] Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis The Nontuberculous Mycobacterial Series
    Kumar, Kartik
    Loebinger, Michael R.
    CHEST, 2022, 161 (03) : 637 - 646
  • [8] Beyond antibiotics for pulmonary nontuberculous mycobacterial disease
    Waterer, Grant
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 260 - 266
  • [9] Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study
    Tan, Yaoju
    Deng, Yunfeng
    Yan, Xiaofeng
    Liu, Fangchao
    Tan, Yunhong
    Wang, Quan
    Bao, Xundi
    Pan, Jianhua
    Luo, Xiaolu
    Yu, Yanhong
    Cui, Xiaoli
    Liao, Guangfu
    Ke, Chunmei
    Xu, Ping
    Li, Xiaofei
    Zhang, Chunlei
    Yao, Xiangyang
    Xu, Ye
    Li, Tongxin
    Su, Biyi
    Chen, Zhenhua
    Ma, Ruiying
    Jiang, Yue
    Ma, Xiaohua
    Bi, Dewu
    Ma, Jinghong
    Yang, Han
    Li, Xuezheng
    Tang, Liusheng
    Yu, Yongmin
    Wang, Yufeng
    Song, Huafeng
    Liu, Hongwei
    Wu, Meiling
    Yang, Yinghui
    Xue, Zhongtan
    Li, Liang
    Li, Qingge
    Pang, Yu
    JOURNAL OF INFECTION, 2021, 83 (01) : 46 - 53
  • [10] Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
    Fujita, Kohei
    Ito, Yutaka
    Yamamoto, Yuki
    Kanai, Osamu
    Imakita, Takuma
    Oi, Issei
    Ito, Takanori
    Saito, Zentaro
    Mio, Tadashi
    BMC PULMONARY MEDICINE, 2022, 22 (01)